Helium Crisis Presents Potential MRI Challenges

The majority of MRI scanners require about 1,500 liters of liquid helium to operate, but geopolitical unrest is putting severe strain on the helium supply chain, potentially reducing access to lifesaving scans.

The supply shock began in March when Iranian missile strikes shut down Qatar’s Ras Laffan Industrial City, which produces roughly 30% of the world’s helium.1 In response, helium prices doubled2 and U.S. distributors began rationing supplies.3

June 10, 2026  — Subtle Medical has received FDA clearance for SubtleHD (CT), an AI-powered image enhancement solution designed to reduce noise and improve low contrast detectability across CT imaging.

The clearance marks Subtle Medical's first product for CT and expands the company's AI-powered imaging portfolio across MRI, PET and CT. It is the company's 11th FDA-cleared product and builds on technology already deployed across more than 1,300 scanners worldwide.

June 15, 2026 – Bayer has announced that the U.S. Food and Drug Administration (FDA) approved Ambelvist (gadoquatrane), a new, intravenous macrocyclic gadolinium (Gd)-based contrast agent (mGBCA) indicated for contrast-enhanced magnetic resonance imaging (MRI) to detect and visualize lesions with abnormal vascularity in the central nervous system (CNS) and non-CNS body regions in adult and pediatric patients, including term neonates.1 Ambelvist is a next-generation mGBCA with a novel tetrameric structure and high relaxivity (a measure of signal enhancement).1

June 8, 2026 — Bruker Corp. has announced the commissioning of a novel BioSpec 18 Tesla preclinical MRI, the world’s highest-field horizontal-bore MRI system, at the Champalimaud Foundation in Lisbon, Portugal.

AccessPoint® by Freeland Systems seamlessly connects enterprise-level clinical imaging, archiving, and structured reporting.

June 15, 2026 — Leica Biosystems is expanding the availability of its Aperio GT Elite digital scanner into the EMEA (Europe, Middle East and Africa) region following its March U.S. launch. Designed for high-throughput workflows, the system helps laboratories scale digital pathology adoption through faster scanning and integrated AI-powered quality control.

June 9, 2026 — An investigator at the Icahn School of Medicine at Mount Sinai has received international recognition for MRI research that may help physicians identify patients at increased risk of chronic kidney disease (CKD) before they undergo surgery for kidney tumors.

June 9, 2026 — Mosaic Clinical Technologies, a wholly owned subsidiary of Radiology Partners, has launched Mosaic Reporting, a new class of AI-native radiology reporting solution available as part of MosaicOS. Mosaic Reporting is already deployed to thousands of radiologists through Radiology Partners-affiliated practices, giving Mosaic a scaled real-world environment to refine and expand the platform.

June 9, 2026 — Bayer has appointed Dr. Jost Reinhard president of the Radiology business within Bayer’s Pharmaceuticals Division, effective Aug. 1, 2026. In his new capacity, he will report to Stefan Oelrich, Member of the Board of Management of Bayer AG and president of the company’s Pharmaceuticals Division. Reinhard follows Nelson Ambrogio, who became president of Bayer U.S. Pharmaceuticals in May.

June 10, 2026 — DeepHealth, Inc., a wholly owned subsidiary of RadNet, has launched Reporting Pro, an AI-powered solution designed to transform the way radiologists generate clinical reports and findings for their referring physicians.  

Reporting Pro includes capabilities that bring speech recognition, AI-generated clinical findings, measurements, AI-generated impressions, quality assurance and structured reporting into one seamless workflow. 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now